The largest pharmaceutical manufacturing company in India, Akums Drugs & Pharmaceuticals, has announced the introduction of 500 mg/5 ml of paracetamol oral suspension to the Indian market. The goal of this potent, simple-to-use formulation is to help adults and elderly patients manage their pain and fever.

By providing therapeutic adult dosage in a small volume, this innovative oral suspension adds to the analgesic and antipyretic class. It responds to the rising need for liquid formulations in India that are appropriate for patients who have trouble swallowing tablets.

One of the most potent liquid paracetamol formulations on the Indian market is 500 mg/5 ml. It lowers dosage frequency and volume by providing an adequate adult dose in just 5ml, which is very helpful in hospital, outpatient, and home care settings throughout India.

It allows for quick symptom treatment, particularly when IV access is not available if oral tablets are uncomfortable or ineffective. The oral suspension promotes improved compliance, particularly in individuals who are elderly, recovering from surgery, or have dysphagia or swallowing issues.

The product also mirrors broader healthcare trends that have been seen in India since the COVID-19 pandemic, including the increase in home-based care and the growing need for treatment formats that are convenient and simple to administer. The formulation has the potential to be expanded into foreign markets with comparable healthcare needs and patient preferences, even if it is being introduced initially for Indian patients.

Also Read: 7 Facts About India’s Pharma Export Growth

This launch demonstrates Akums’ strategic focus on unique dosage forms and practical applicability, further solidifying the company’s leadership in the Indian market for pain and fever management. The formulation has the potential to be expanded into foreign markets with comparable healthcare needs and patient preferences, even if it is being introduced initially for Indian patients.

The top contract development and manufacturing organization (CDMO) in India is Akums Drugs & Pharmaceuticals, which provides comprehensive pharmaceutical solutions ranging from large-scale manufacturing to regulatory support and research and development.

With more than 4,000 marketed formulations and more than 15 cutting-edge facilities, Akums provides a wide range of therapeutic areas to more than 1,500 domestic and international clients.